ARTICLE | Company News
Vernalis in second deal with Lilly
March 19, 2001 8:00 AM UTC
Eli Lilly (LLY) has taken an option to develop Vernalis' VML 670 to treat sexual dysfunction in patients taking selective serotonin reuptake inhibitors for depression. Vernalis (LSE:VER) will carry ou...